Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance
- Posted on May 12, 2026
- By CNBC
- 0 Views
- 1 min read
Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
